Transmission of human herpesvirus 8 by blood transfusion.
about
Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, ChinaBlood transfusion safety in Africa: a literature review of infectious disease and organizational challengesKSHV: pathways to tumorigenesis and persistent infectionTransfusion-transmitted infectionsHuman herpesvirus 8 seropositivity among sexually active adults in UgandaPrimary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case reportIncidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections.Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerSeroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in ChinaHuman herpesvirus-8 in northwestern China: epidemiology and characterization among blood donorsSeroprevalence of human herpesvirus 8 and hepatitis C virus among drug users in Shanghai, China.Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt"Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions.Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theHuman herpesviruses 6, 7, and 8 from a dermatologic perspective.Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.KSHV LANA--the master regulator of KSHV latency.Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic areaPathology of Kaposi's Sarcoma-Associated Herpesvirus InfectionHuman herpesvirus 8 seroprevalence, China.A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis.Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivoKaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection.Critical evaluation of justifications for the transfusion of red blood cells: the reality of a government emergency hospital.Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric PopulationHepatic Kaposi sarcoma: A case report and review of the literature.Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmissionAssociation between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality.Kaposi sarcoma herpesvirus pathogenesis.Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection.Increased prevalence of human herpesvirus type 8 (HHV-8) genome among blood donors from North-Western Argentina.Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.KSHV and the Role of Notch Receptor Dysregulation in Disease Progression.
P2860
Q21245098-893A7C23-C2B2-4B0B-9B04-7CB717E3DFC9Q26866294-7A8D7A6F-7A6E-4930-94A3-2AD5EF9E4EB9Q27026000-56D60DDF-47C1-4DFB-95A3-1026E28397E6Q27480405-F7F5D1BC-90DC-4D68-A8BA-F5ED0EEB77A6Q28743392-EA7BB484-8349-416E-8A51-2C5B11B91C21Q30399671-D34E461A-D4FC-4C16-84A0-7C91A0F322AEQ33308333-58501E45-8F23-48F4-8143-9D98DC4D51D3Q33360459-FB5061D3-02C2-4768-AC79-763AA1CDCDD3Q33507742-94AFEE54-48FF-4A99-8AA9-32E718B8092DQ33650105-5DAB0B68-8133-48CD-8E79-6F8B503ABFCCQ33742831-D5F5BEAE-B1DF-47B4-BA42-C34E1353EF48Q33780383-3B1A0D0F-C5DB-41EE-9A5C-D9D4BFDB7D91Q33820738-A3630D1F-66B9-4B42-912C-CD78B19E7AC6Q33952679-8A26D9C0-907B-4A15-B652-B4C5ACB10E69Q33999780-612CD6DE-A1F0-4C5A-8390-545248F92FD0Q34168712-A9674222-CE48-411E-A9D2-6BD137379588Q34187052-6523E798-5C17-4E8B-B6CB-D75A031425CFQ34212799-802B8354-053A-4799-96F8-46844377F9F4Q34346918-DA201571-7584-4E00-9CD4-E4382FF296FEQ34446582-5B3BFEB0-5A25-437A-AEFE-B1212C96DAE5Q34597442-A6BA52BC-04A5-476E-ADAC-03B7C4BC4C4CQ34774797-A4FC0033-FBB7-4839-9455-E9C8BEA176CDQ34783313-3EFFC001-D49C-4C71-9D69-A459AB3B7909Q35179783-E992A77C-8412-498C-A05D-15DB6B2E8C1CQ35845813-8D9A0507-577F-4931-893E-BA1A6C42B0CBQ36689882-3AD2DEA3-B935-4A4E-8750-B0198D5FEB2DQ36760054-6AEA4E18-9D8D-4338-ABF3-512960D1E2DAQ37173586-AD63FFF1-84B2-4ECC-AC9E-67C7832E57A4Q37190897-D53F7A7D-05C3-4423-A02B-5F9142B7398CQ37212619-307E57A1-FD3F-4793-9104-C44B8E48876AQ37234113-0296CCCA-5778-4970-A0DD-9BA7020674DEQ37600164-158A48B0-AF14-4C71-9F54-A4EC809894ACQ37628536-5EDBA298-553F-47B3-9487-F92CB8859811Q37684392-9016FAC8-0B83-4A33-9A1E-EF9BD97AC5B5Q38867266-789B30C5-1430-4036-84F3-5E21D48AF217Q40046587-47D047BE-5BF9-4477-89B1-DFAF285C1860Q40566592-F5C16D23-14BE-4885-B2B1-0C7C44B06378Q40582724-F9DE3D57-940C-4027-BF75-E651F84CD527Q40665110-21B6F002-966B-4984-8CA2-E02AAB424042Q41662283-2B8D39C5-B989-43CE-A04B-B50CFE1F0F44
P2860
Transmission of human herpesvirus 8 by blood transfusion.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Transmission of human herpesvirus 8 by blood transfusion.
@ast
Transmission of human herpesvirus 8 by blood transfusion.
@en
Transmission of human herpesvirus 8 by blood transfusion.
@nl
type
label
Transmission of human herpesvirus 8 by blood transfusion.
@ast
Transmission of human herpesvirus 8 by blood transfusion.
@en
Transmission of human herpesvirus 8 by blood transfusion.
@nl
prefLabel
Transmission of human herpesvirus 8 by blood transfusion.
@ast
Transmission of human herpesvirus 8 by blood transfusion.
@en
Transmission of human herpesvirus 8 by blood transfusion.
@nl
P2093
P356
P1476
Transmission of human herpesvirus 8 by blood transfusion
@en
P2093
Ashley L Fowlkes
Esau Nzaro
Eve M Lackritz
Flora Banage
Jonathan Mermin
Minal M Amin
Peter Kataaha
Robert Downing
Sheila C Dollard
Timothy J Dondero
P304
P356
10.1056/NEJMOA055009
P407
P50
P577
2006-09-01T00:00:00Z